What is Cavitation Technologies Inc's earnings per share (EPS)?

Cavitation Technologies Inc (CVAT) reported diluted earnings per share of $0.00 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Cavitation Technologies Inc (CVAT) Financials

CVAT

FY2025 annual

Revenue $203K -85.1% YoY

Net Income -$113K -125.7% YoY

EPS (Diluted) $0.00 YoY not available

Operating Cash Flow -$806K -568.6% YoY

Market Cap $15.5M as of Sep 3, 2026

Price / Sales 76.4x on $203K revenue, FY2025

Price / Earnings n/m net loss, so no earnings multiple, FY2025

Price / Book n/m negative shareholder equity, so no book multiple, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Mar 31, 2026 Reported May 20, 2026 Currency USD FYE June

Newest figures come from the 10-Q for Q3 FY2026, filed May 20, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CVAT SEC filings page.

Cavitation Technologies Inc (CVAT) reported $203K in revenue for fiscal year 2025, down 85.1% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CVAT FY2025 2026-08-29

Cavitation Technologies’ low-volume, high-overhead model makes modest sales swings dominate profitability and cash generation.

FY2024 net income of $439K converted to only $172K of operating cash flow, a partial cash-conversion result showing reported profit did not fully become operating liquidity. In FY2025, net income was -$113K alongside operating cash flow of -$806K, so the bottom line materially understated cash demands from the business.

Gross margin narrowed from 88.6% in FY2024 to 81.3% in FY2025, remaining high but providing less protection. Operating margin moved from 32.1% to -486.2%, indicating overhead absorption, rather than product costs, determined the earnings swing.

The FY2025 current ratio was 3.7x, meaning current assets exceeded current liabilities, but total liabilities of $228K compared with equity of $69K leaves a thin capital cushion. The reported liquidity measure equaled 3.7 months of the latest annual operating outflow, while investing cash flow of $880K offset operating cash flow of -$806K; cash movement therefore depended on investing activity, not operations.

Financial Health Signals

Financial health score not available

Cavitation Technologies Inc does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Distress

-95.71

Cavitation Technologies Inc scores -95.71, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($15.5M) relative to total liabilities ($228K). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Weak

2/9

Cavitation Technologies Inc passes 2 of 9 financial strength tests. No profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality No Cash Backing

N/A

Cavitation Technologies Inc reported a net loss of $113K while operations used $806K of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

Cavitation Technologies Inc reported an operating loss of $987K against $6K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$3K

YoY-97.5%

Cavitation Technologies Inc generated $3K in revenue in Q3 2026. This represents a decrease of 97.5% from the same quarter a year earlier.

Net Income

-$219K

YoY+4.8%

Cavitation Technologies Inc reported -$219K in net income in Q3 2026. This represents an increase of 4.8% from the same quarter a year earlier.

EPS (Diluted)

$0.00

Cavitation Technologies Inc earned $0.00 per diluted share (EPS) in Q3 2026.

EBITDA

Not reported for Q3 2026.

Cash & Balance Sheet

Cash & Debt

$45K

YoY-89.6%

QoQ+45.2%

5Y CAGR-44.3%

10Y CAGR-24.3%

Cavitation Technologies Inc held $45K in cash against $150K in long-term debt as of Q3 2026.

Shares Outstanding

310M

YoY+7.2%

QoQ0.0%

5Y CAGR+9.5%

10Y CAGR+4.8%

Cavitation Technologies Inc had 310M shares outstanding in Q3 2026. This represents an increase of 7.2% from the same quarter a year earlier. It is unchanged from the prior quarter.

Free Cash Flow

Not reported for Q3 2026.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Gross Margin

100.0%

YoY+20.5pp

Cavitation Technologies Inc's gross margin was 100.0% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is up 20.5 percentage points from the same quarter a year earlier.

Operating Margin

Not shown for Q3 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not shown for Q3 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Return on Equity

Not reported for Q3 2026.

Capital Allocation

None of these metrics is reported for Q3 2026.

CVAT Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CVAT quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	N/A	$203K-85.1%	$1.4M+214.8%	$433K-73.3%	$1.6M+190.1%	$558K-66.4%	$1.7M+52.6%	$1.1M-16.3%	$1.3M-31.3%	$1.9M+5.5%	$1.8M+267.5%	$489K-73.6%	$1.9M+47.3%	$1.3M+572.8%	$187K-68.3%	$590K
Cost of Revenue	N/A	$38K-75.6%	$156K+28.9%	$121K+195.1%	$41K+105.0%	$20K-50.0%	$40K-42.0%	$69K-43.4%	$122K+25.8%	$97K-20.2%	$122K+65.9%	$73K-39.0%	$120K+285.5%	$31K-23.1%	$41K-55.5%	$91K
Gross Profit	N/A	$165K-86.3%	$1.2M+286.9%	$312K-80.2%	$1.6M+193.3%	$538K-66.9%	$1.6M+59.0%	$1.0M-13.5%	$1.2M-34.4%	$1.8M+7.4%	$1.7M+303.1%	$416K-76.0%	$1.7M+41.3%	$1.2M+737.7%	$147K-70.6%	$499K
R&D Expenses	N/A	$95K+55.7%	$61K+1933.3%	$3K-82.4%	$17K-19.0%	$21K+16.7%	$18K-28.0%	$25K0.0%	$25K-7.4%	$27K-8.1%	$29K+31.6%	$22K-45.3%	$41K-70.9%	$140K-7.7%	$152K-77.1%	$665K
SG&A Expenses	N/A	$1.1M+49.3%	$708K-40.8%	$1.2M-30.8%	$1.7M+36.7%	$1.3M-14.0%	$1.5M-14.5%	$1.7M+14.1%	$1.5M-24.8%	$2.0M+65.1%	$1.2M-31.5%	$1.8M-27.5%	$2.4M+26.8%	$1.9M+12.1%	$1.7M	N/A
Operating Income	N/A	-$987K-325.3%	$438K+149.4%	-$886K-196.3%	-$299K+60.0%	-$747K-649.3%	$136K+118.8%	-$723K-106.0%	-$351K-51.3%	-$232K	N/A	N/A	-$749K+10.7%	-$840K+51.4%	-$1.7M	N/A
EBITDA	N/A	-$987K-324.8%	$439K+149.7%	-$883K-195.3%	-$299K+58.8%	-$725K-514.3%	$175K+125.7%	-$682K-127.3%	-$300K-66.7%	-$180K	N/A	N/A	-$649K+6.9%	-$697K+58.4%	-$1.7M	N/A
Interest Expense	N/A	$6K+700.0%	-$1K-116.7%	$6K+20.0%	$5K-16.7%	$6K	$0	N/A	N/A	N/A	N/A	N/A	N/A	$10K	N/A	N/A
Income Tax	N/A	N/A	N/A	$0	$0	$0	$0	$0	N/A	N/A	$0	N/A	$0	$0	$0	$0
Net Income	N/A	-$113K-125.7%	$439K+121.5%	-$2.0M-229.6%	-$619K+4.6%	-$649K-607.0%	$128K+117.7%	-$723K-189.2%	-$250K-7.3%	-$233K-153.8%	$433K+131.4%	-$1.4M+36.9%	-$2.2M-121.1%	-$988K+48.8%	-$1.9M	N/A
EPS (Basic)	N/A	$0.00	$0.00+100.0%	-$0.01	$0.00	$0.00	N/A	N/A	N/A	N/A	N/A	N/A	-$0.010.0%	-$0.01	N/A	N/A
EPS (Diluted)	$0.00	$0.00	$0.00+100.0%	-$0.01	$0.00	$0.00	N/A	N/A	N/A	N/A	N/A	N/A	-$0.01	-$0.01	N/A	N/A
Diluted Shares (Avg)	N/A	286M+0.6%	284M+0.9%	282M+13.2%	249M+26.1%	197M+0.1%	197M-0.5%	198M+0.4%	197M+1.1%	195M+0.4%	194M+6.0%	183M+14.2%	161M	160M	N/A	N/A

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Revenue	$3K-97.5%	$0-100.0%	$3K	N/A	$122K-76.5%	$76K-60.4%	$0	N/A
Cost of Revenue	$0-100.0%	$0-100.0%	N/A	N/A	$25K+257.1%	$13K-61.8%	N/A	N/A
Gross Profit	$3K-96.9%	$0-100.0%	N/A	N/A	$97K-81.1%	$63K-60.1%	N/A	N/A
R&D Expenses	N/A	$4K-75.0%	$7K-12.5%	N/A	$42K+366.7%	$16K	$8K-77.8%	N/A
SG&A Expenses	$234K-17.3%	N/A	$245K+12.4%	N/A	$283K+66.5%	$346K+101.2%	$218K+1.9%	N/A
Operating Income	-$231K-1.3%	N/A	-$249K-10.2%	N/A	-$228K-168.5%	-$299K-2035.7%	-$226K+9.6%	N/A
EBITDA	N/A	N/A	N/A	N/A	-$228K-168.5%	N/A	N/A	N/A
Interest Expense	$3K+50.0%	$2K0.0%	$9K+800.0%	N/A	$2K0.0%	$2K0.0%	$1K0.0%	N/A
Net Income	-$219K+4.8%	N/A	-$258K-13.7%	N/A	-$230K-169.5%	$579K+3718.8%	-$227K+9.6%	N/A
EPS (Basic)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00+100.0%
EPS (Diluted)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00+100.0%
Diluted Shares (Avg)	310M+8.1%	301M+5.9%	289M+1.7%	N/A	286M+0.8%	284M0.0%	284M0.0%	N/A

Not reported in any period shown, so not listed: Income Tax.

CVAT Balance Sheet

CVAT quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$297K+19.8%	$248K+73.4%	$143K-92.4%	$1.9M+2.2%	$1.8M+40.4%	$1.3M+27.7%	$1.0M-5.4%	$1.1M+16.0%	$930K-3.1%	$960K-45.5%	$1.8M+13.1%	$1.6M+160.1%	$599K+5.0%	$570K+43.5%	$398K
Current Assets	$286K+46.7%	$195K+983.3%	$18K-96.6%	$528K-62.1%	$1.4M+53.2%	$910K-3.8%	$946K-3.4%	$979K+26.0%	$777K-4.2%	$811K-49.7%	$1.6M+20.2%	$1.3M+280.7%	$353K+16.8%	$302K+173.2%	$111K
Cash & Equivalents	$249K+39.1%	$179K+894.4%	$18K-95.9%	$441K-67.6%	$1.4M+79.6%	$759K+16.9%	$649K-31.3%	$945K+72.1%	$549K-16.4%	$657K-55.6%	$1.5M+20.6%	$1.2M+406.9%	$242K+76.3%	$137K+828.7%	$15K
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	N/A	$0	$0-100.0%	$48K+92.0%	$25K-46.8%	$47K-17.5%	$57K+67.6%	$34K-76.2%	$143K-7.0%	$154K+13.4%	$136K+16.3%	$117K+8.3%	$108K-23.6%	$141K+52.5%	$92K
Accounts Receivable	$10K	$0	$0-100.0%	$1K-83.3%	$6K-94.2%	$104K-56.7%	$240K	$0-100.0%	$85K	N/A	$0	N/A	N/A	N/A	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$228K-68.7%	$728K-31.5%	$1.1M+27.2%	$835K-62.8%	$2.2M+25.0%	$1.8M-2.5%	$1.8M+13.3%	$1.6M+30.9%	$1.2M-22.6%	$1.6M-43.5%	$2.8M+46.3%	$1.9M-28.8%	$2.7M+7.5%	$2.5M+122.7%	$1.1M
Current Liabilities	$78K-87.0%	$598K-30.8%	$864K+54.8%	$558K-68.9%	$1.8M+25.3%	$1.4M-22.2%	$1.8M+13.3%	$1.6M+30.9%	$1.2M-22.6%	$1.6M-43.5%	$2.8M+46.3%	$1.9M-28.8%	$2.7M+7.5%	$2.5M+122.7%	$1.1M
Non-Current Liabilities	$150K+15.4%	$130K-34.3%	$198K-28.5%	$277K-38.0%	$447K+23.5%	$362K	$0	$0	$0-100.0%	$225	$0	$0	$0	$0	$0
Long-Term Debt	$150K+15.4%	$130K-10.3%	$145K-3.3%	$150K-40.9%	$254K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$69K+114.4%	-$480K+47.8%	-$919K-188.7%	$1.0M+352.1%	-$411K+16.1%	-$490K+40.2%	-$819K-50.3%	-$545K-75.2%	-$311K+51.6%	-$643K+40.2%	-$1.1M-181.5%	-$382K+82.0%	-$2.1M-8.3%	-$2.0M-165.3%	-$740K
Retained Earnings	-$27.0M-0.4%	-$26.8M+1.6%	-$27.3M-8.1%	-$25.2M-2.5%	-$24.6M-2.7%	-$24.0M+0.5%	-$24.1M-3.1%	-$23.4M-1.1%	-$23.1M-1.0%	-$22.9M+1.9%	-$23.3M-6.3%	-$22.0M-11.1%	-$19.8M-5.3%	-$18.8M-11.5%	-$16.8M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Total Assets	$66K-88.5%	$55K-92.3%	$60K-22.1%	$297K+19.8%	$576K+109.5%	$718K+647.9%	$77K-68.8%	$248K+73.4%
Current Assets	$55K-90.3%	$44K-93.7%	$49K+16.7%	$286K+46.7%	$565K+177.0%	$701K+9914.3%	$42K-70.0%	$195K+983.3%
Cash & Equivalents	$45K-89.6%	$31K-95.4%	$30K+1400.0%	$249K+39.1%	$432K+136.1%	$681K+9628.6%	$2K-98.6%	$179K+894.4%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	N/A	N/A	N/A	N/A	N/A	$11K	N/A	$0
Accounts Receivable	$3K-97.5%	$0	$5K	$10K	$122K+542.1%	$0	$0	$0
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$533K+92.4%	$303K-59.1%	$249K-68.2%	$228K-68.7%	$277K-75.5%	$741K-42.2%	$784K-44.7%	$728K-31.5%
Current Liabilities	$383K+155.3%	$153K-75.0%	$99K-84.9%	$78K-87.0%	$150K-84.8%	$613K-45.5%	$656K-47.0%	$598K-30.8%
Non-Current Liabilities	$150K+18.1%	$150K+17.2%	$150K+17.2%	$150K+15.4%	$127K-12.4%	$128K-19.0%	$128K-28.5%	$130K-34.3%
Long-Term Debt	$150K+18.1%	$150K+17.2%	$150K+17.2%	$150K+15.4%	$127K	$128K	$128K	$130K-10.3%
Total Equity	-$467K-256.2%	-$248K-978.3%	-$189K+73.3%	$69K+114.4%	$299K+135.0%	-$23K+98.1%	-$707K+39.6%	-$480K+47.8%
Retained Earnings	-$27.9M-4.4%	-$27.7M-4.5%	-$27.2M-0.5%	-$27.0M-0.4%	-$26.7M+1.8%	-$26.5M+3.8%	-$27.1M+1.7%	-$26.8M+1.6%

Not reported in any period shown, so not listed: Goodwill.

CVAT Cash Flow Statement

CVAT quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	-$709K	-$806K-568.6%	$172K+140.7%	-$423K+12.6%	-$484K-93.6%	-$250K-546.4%	$56K+120.0%	-$280K-170.7%	$396K+861.5%	-$52K+93.2%	-$760K-654.4%	-$101K-415.5%	$32K-95.5%	$709K+769.5%	-$106K+82.8%	-$614K
Depreciation & Amortization	N/A	$0-100.0%	$1K-66.7%	$3K	$0-100.0%	$22K-43.6%	$39K-4.9%	$41K-19.6%	$51K-1.9%	$52K-13.5%	$60K-33.0%	$90K-10.8%	$101K-29.6%	$143K+182.8%	$51K+139.3%	$21K
Stock-Based Compensation	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$449K	$0	N/A	N/A	N/A	$0-100.0%	$113K-48.9%	$222K	$0
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	$128K+156.0%	$50K+212.5%	$16K	$0-100.0%	$56K-9.0%	$62K+170.6%	$23K-47.4%	-$43K-52.0%	$90K	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	-$378K-6400.0%	$6K+102.0%	-$296K-174.7%	$396K+466.7%	-$108K+86.8%	-$821K-565.2%	-$123K-988.2%	-$11K-101.8%	$619K	N/A	N/A
Investing Cash Flow	N/A	$880K	$0	$0+100.0%	-$1.2M-855.5%	-$128K-156.0%	-$50K-212.5%	-$16K	$0+100.0%	-$56K+9.0%	-$62K-170.6%	-$23K+67.0%	-$69K+42.9%	-$121K-125.0%	-$54K+56.6%	-$123K
Financing Cash Flow	$322K	-$4K+63.6%	-$11K	$0-100.0%	$785K-20.1%	$982K+844.2%	$104K	$0	N/A	N/A	$0-100.0%	$375K-63.2%	$1.0M+311.2%	-$484K-271.5%	$282K-62.5%	$752K
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0-100.0%	$25K	$0	N/A

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Operating Cash Flow	-$126K+49.2%	-$182K+9.5%	-$219K-25.1%	-$182K-2700.0%	-$248K-240.9%	-$201K-51.1%	-$175K-243.4%	$7K+102.4%
Depreciation & Amortization	N/A	N/A	N/A	$0	$0	N/A	N/A	$0-100.0%
Investing Cash Flow	$0	N/A	N/A	$0	$0	N/A	N/A	$0
Financing Cash Flow	$140K+14100.0%	$183K	$0+100.0%	-$1K+90.9%	-$1K	$0	-$2K	-$11K

Not reported in any period shown, so not listed: Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.

CVAT Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CVAT quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	81.3%-7.3pp	88.5%+16.5pp	72.1%-25.4pp	97.5%+1.1pp	96.4%-1.2pp	97.6%+3.9pp	93.7%+3.0pp	90.6%-4.2pp	94.9%+1.6pp	93.2%+8.2pp	85.0%-8.5pp	93.5%-4.0pp	97.5%+19.2pp	78.3%-6.2pp	84.5%
Operating Margin	-486.2%	32.1%	-204.6%	-18.5%	-133.9%	8.2%+74.5pp	-66.3%-39.4pp	-26.9%-14.7pp	-12.2%	N/A	N/A	-40.4%+26.3pp	-66.6%	-921.7%	N/A
Net Margin	-55.7%-87.9pp	32.2%	-471.1%	-38.2%	-116.3%	7.7%+74.0pp	-66.3%-47.1pp	-19.2%-6.9pp	-12.3%-36.4pp	24.1%	-281.8%	-117.7%	-78.5%	-1029.9%	N/A
Return on Equity	-163.8%	N/A	N/A	-59.8%	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	-38.0%-215.1pp	177.0%+1603.6pp	-1426.6%-1393.5pp	-33.1%+2.4pp	-35.4%-45.3pp	9.8%+80.6pp	-70.8%-47.6pp	-23.2%+1.9pp	-25.1%-70.2pp	45.1%+123.4pp	-78.3%+62.0pp	-140.3%+24.8pp	-165.0%+173.0pp	-338.0%	N/A
Current Ratio	3.67+3.3x	0.33+0.3x	0.02-0.9x	0.95+0.2x	0.78+0.1x	0.64+0.1x	0.51-0.1x	0.600.0x	0.63+0.1x	0.51-0.1x	0.57-0.1x	0.69+0.6x	0.130.0x	0.120.0x	0.10
Debt-to-Equity	2.17	N/A	N/A	0.14	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Asset Turnover	0.68-4.8x	5.50+2.5x	3.03+2.2x	0.87+0.6x	0.30-1.0x	1.28+0.2x	1.07-0.1x	1.21-0.8x	2.04+0.2x	1.87+1.6x	0.28-0.9x	1.19-0.9x	2.10+1.8x	0.33-1.2x	1.48
FCF Margin	N/A	N/A	N/A	N/A	-67.7%-68.1pp	0.4%+27.5pp	-27.2%-57.6pp	30.4%+36.1pp	-5.7%+40.0pp	-45.7%-20.4pp	-25.2%-24.6pp	-0.6%-49.7pp	49.1%	N/A	N/A

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Gross Margin	100.0%+20.5pp	N/A	N/A	N/A	79.5%-19.1pp	82.9%+0.6pp	N/A	N/A
Operating Margin	-7700.0%	N/A	-8300.0%	N/A	-186.9%	-393.4%	N/A	N/A
Net Margin	-7300.0%	N/A	-8600.0%	N/A	-188.5%	761.8%	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	-76.9%	N/A	N/A	N/A
Return on Assets	-331.8%-291.9pp	N/A	-430.0%-135.2pp	N/A	-39.9%-160.3pp	80.6%+97.3pp	-294.8%-193.2pp	N/A
Current Ratio	0.14-3.6x	0.29-0.9x	0.49+0.4x	3.67+3.3x	3.77+3.6x	1.14+1.1x	0.060.0x	0.33+0.3x
Debt-to-Equity	N/A	N/A	N/A	2.17	0.42	N/A	N/A	N/A
Asset Turnover	0.05-0.2x	0.00-0.1x	0.05+0.1x	N/A	0.21-1.7x	0.11-1.9x	0.000.0x	N/A

Not reported in any period shown, so not listed: FCF Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Cavitation Technologies Inc CVAT	FY2025	$203K	-$113K	-55.7%	$15.5M	—
Newhydrogen Inc NEWH	FY2025	N/A	-$2.8M	N/A	$12.5M	—

Where Cavitation Technologies Inc Ranks

Frequently Asked Questions

What is Cavitation Technologies Inc's annual revenue?

Cavitation Technologies Inc (CVAT) reported $203K in total revenue for fiscal year 2025. This represents a -85.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Cavitation Technologies Inc's revenue growing?

Cavitation Technologies Inc (CVAT) revenue declined by 85.1% year-over-year, from $1.4M to $203K in fiscal year 2025.

Is Cavitation Technologies Inc profitable?

No, Cavitation Technologies Inc (CVAT) reported a net income of -$113K in fiscal year 2025, with a net profit margin of -55.7%.

What is Cavitation Technologies Inc's EBITDA?

Cavitation Technologies Inc (CVAT) had EBITDA of -$987K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Cavitation Technologies Inc have?

As of fiscal year 2025, Cavitation Technologies Inc (CVAT) had $249K in cash and equivalents against $150K in long-term debt.

What is Cavitation Technologies Inc's gross margin?

Cavitation Technologies Inc (CVAT) had a gross margin of 81.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Cavitation Technologies Inc's net profit margin?

Cavitation Technologies Inc (CVAT) had a net profit margin of -55.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Cavitation Technologies Inc's return on equity (ROE)?

Cavitation Technologies Inc (CVAT) has a return on equity of -163.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Cavitation Technologies Inc's operating cash flow?

Cavitation Technologies Inc (CVAT) recorded an outflow of $806K in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are Cavitation Technologies Inc's total assets?

Cavitation Technologies Inc (CVAT) had $297K in total assets as of fiscal year 2025, including both current and long-term assets.

How much does Cavitation Technologies Inc spend on research and development?

Cavitation Technologies Inc (CVAT) invested $95K in research and development during fiscal year 2025.

How many shares does Cavitation Technologies Inc have outstanding?

Cavitation Technologies Inc (CVAT) had 289M shares outstanding as of fiscal year 2025.

What is Cavitation Technologies Inc's current ratio?

Cavitation Technologies Inc (CVAT) had a current ratio of 3.67 as of fiscal year 2025, which is generally considered healthy.

What is Cavitation Technologies Inc's debt-to-equity ratio?

Cavitation Technologies Inc (CVAT) had a debt-to-equity ratio of 2.17 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Cavitation Technologies Inc's return on assets (ROA)?

Cavitation Technologies Inc (CVAT) had a return on assets of -38.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Cavitation Technologies Inc's P/E ratio?

Cavitation Technologies Inc (CVAT) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $15.5M as of Sep 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Cavitation Technologies Inc's price-to-sales ratio?

Cavitation Technologies Inc (CVAT) trades at 76.4x sales, its market capitalization divided by revenue of $203K revenue, FY2025. The market capitalization is $15.5M as of Sep 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

How does Cavitation Technologies Inc's liquidity compare with its operating cash outflow?

At the end of fiscal year 2025, Cavitation Technologies Inc (CVAT) held $249K in cash, cash equivalents and investments, and reported an operating cash outflow of $806K over that year. Dividing the one by the other, the reported balance equals about 4 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

What is Cavitation Technologies Inc's Altman Z-Score?

Cavitation Technologies Inc (CVAT) has an Altman Z-Score of -95.71, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Cavitation Technologies Inc's Piotroski F-Score?

Cavitation Technologies Inc (CVAT) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Cavitation Technologies Inc's earnings high quality?

Cavitation Technologies Inc (CVAT) reported a net loss of $113K while operations used $806K of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Cavitation Technologies Inc cover its interest payments?

Cavitation Technologies Inc (CVAT) reported an operating loss of $987K against $6K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.